Sundance Strategies (SUND) 10-Q 5 Apr 19 2018 Q1 Quarterly report Financial data

DOCUMENT AND ENTITY INFORMATION

DOCUMENT AND ENTITY INFORMATION - shares	3 Months Ended
	Jun. 30, 2017	Apr. 05, 2019
Document And Entity Information [Abstract]
Document Type	10-Q
Amendment Flag	false
Document Period End Date	Jun. 30, 2017
Document Fiscal Year Focus	2018
Document Fiscal Period Focus	Q1
Entity Registrant Name	Sundance Strategies, Inc.
Entity Central Index Key	0001171838
Current Fiscal Year End Date	--03-31
Entity Filer Category	Smaller Reporting Company
Entity Common Stock, Shares Outstanding		37,828,441

Condensed Consolidated Balance

Condensed Consolidated Balance Sheets - USD ($)	Jun. 30, 2017	Mar. 31, 2017
Current Assets
Cash and Cash Equivalents	$ 35,178	$ 4,364
Prepaid Expenses and Other Assets	2,205	4,705
Investment in Net Insurance Benefits	7,769,568	34,156,005
Total Current Assets	7,806,951	34,165,074
Current Liabilities
Accounts Payable	540,820	508,071
Deferred Income Taxes		758,972
Notes Payable, Related Parties	4,718,484	5,214,753
Convertible Debenture	700,000	700,000
Accrued Expenses	402,625	753,780
Total Current Liabilities	6,361,929	7,935,576
Commitments and Contingencies (Note 8)
Stockholders' Equity
Preferred Stock, authorized 10,000,000 shares, par value $0.001; -0- shares issued and outstanding
Common Stock, authorized 500,000,000 shares, par value $0.001; 44,128,441 shares issued and outstanding	44,129	44,129
Additional Paid In Capital	24,547,014	24,547,014
Retained Earnings (Accumulated Deficit)	(23,146,121)	1,638,355
Total Stockholders' Equity	1,445,022	26,229,498
Total Liabilities and Stockholders' Equity	$ 7,806,951	$ 34,165,074

Condensed Consolidated Balanc_2

Condensed Consolidated Balance Sheets (Parenthetical) - $ / shares	Jun. 30, 2017	Mar. 31, 2017
Statement of Financial Position [Abstract]
Preferred Stock, shares authorized	10,000,000	10,000,000
Preferred Stock, par value per share	$ 0.001	$ 0.001
Preferred Stock, shares issued	0	0
Preferred Stock, shares outstanding	0	0
Common Stock, shares authorized	500,000,000	500,000,000
Common Stock, par value per share	$ 0.001	$ 0.001
Common Stock, shares issued	44,128,441	44,128,441
Common Stock, shares outstanding	44,128,441	44,128,441

Condensed Consolidated Statemen

Condensed Consolidated Statements of Operations (Unaudited) - USD ($)	3 Months Ended
	Jun. 30, 2017	Jun. 30, 2016
Income Statement [Abstract]
Interest Income on Investment in Net Insurance Benefits		$ 1,453,872
General and Administrative Expenses	547,581	727,443
Impairment of Accrued Interest Receivable on Net Insurance Benefits	1,936,311
Income (Loss) from Operations	(2,483,892)	726,429
Other Expense
Impairment of Investment in Net Insurance Benefits	(22,950,126)
Interest Expense	(109,430)	(85,882)
Total Other Expense	(23,059,556)	(85,882)
Income (Loss) Before Income Taxes	(25,543,448)	640,547
Income Tax Provision	(758,972)
Net Income (Loss)	$ (24,784,476)	$ 640,547
Basic and Diluted:
Basic Earnings (Loss) Per Share	$ (0.56)	$ 0.01
Diluted Earnings (Loss) Per Share	$ (0.56)	$ 0.01
Basic Weighted Average Number of Shares Outstanding	44,128,441	44,140,669
Diluted Weighted Average Number of Shares Outstanding	44,128,441	45,482,299

Condensed Consolidated Statem_2

Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)	3 Months Ended
	Jun. 30, 2017	Jun. 30, 2016
Operating Activities
Net Income (Loss)	$ (24,784,476)	$ 640,547
Adjustments to reconcile to net cash from operating activities:
Share Based Compensation - Options		103,843
Impairment of Net Insurance Benefits	24,886,437
Deferred Income Taxes	(758,972)
Accrued Interest on Net Insurance Benefits		(1,453,872)
Changes in Operating Assets and Liabilities
Accrued Interest Income		(2,204)
Cash Received on Net Insurance Benefits	1,500,000	1,417,870
Prepaid Expenses and Other Assets	2,500	(8,125)
Accounts Payable	32,749	38,265
Accrued Expenses	(351,155)	(59,787)
Net Cash from Operating Activities	527,083	676,537
Financing Activities
Proceeds from Convertible Debenture	200,000
Repayment of Convertible Debenture	(200,000)
Proceeds from Issuance of Notes Payable, Related Party		205,000
Repayment of Notes Payable, Related Party	(496,269)	(150,000)
Redemption of Mandatorily Redeemable Common Stock		(750,000)
Net Cash from Financing Activities	(496,269)	(695,000)
Net Change in Cash and Cash Equivalents	30,814	(18,463)
Cash and Cash Equivalents at Beginning of Period	4,364	24,717
Cash and Cash Equivalents at End of Period	35,178	6,254
Non Cash Financing & Investing Activities, and Other Disclosures
Cash Paid for Interest	415,519
Cash Paid for Income Taxes

ORGANIZATION AND BASIS OF PRESE

ORGANIZATION AND BASIS OF PRESENTATION	3 Months Ended
	Jun. 30, 2017
Organization, Consolidation and Presentation of Financial Statements [Abstract]
ORGANIZATION AND BASIS OF PRESENTATION	(1) ORGANIZATION AND BASIS OF PRESENTATION The accompanying interim condensed consolidated financial statements have been prepared by the Company, without audit, in accordance with the instructions to the Quarterly Report on Form 10-Q, and Rule 10-01 of Regulation S-X promulgated by the United States Securities and Exchange Commission (the “SEC”) and, therefore, do not include all information and footnotes necessary for a fair presentation of its consolidated financial position, results of operations and cash flows in accordance with accounting principles generally accepted in the United States (“GAAP”). In the opinion of management, the condensed consolidated unaudited financial information for the interim periods presented reflects all adjustments, consisting of only normal and recurring adjustments, necessary for a fair presentation of the Company’s consolidated financial position, results of operations, and cash flows for the periods presented. These condensed consolidated financial statements should be read in conjunction with the consolidated financial statements included in the Company’s Annual Report on Form 10-K for the fiscal year ended March 31, 2017. Operating results for interim periods are not necessarily indicative of operating results for an entire fiscal year. The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts and the disclosure of contingent amounts in the Company’s financial statements and the accompanying notes. Actual results could materially differ from those estimates. Sundance Strategies, Inc. (formerly known as Java Express, Inc.) was organized under the laws of the State of Nevada on December 14, 2001, and engaged in the retail selling of beverage products to the general public until these endeavors ceased in 2006; it had no material business operations from 2006, until its acquisition of ANEW LIFE, INC. (“ANEW LIFE”), a subsidiary of Sundance Strategies, Inc. (“Sundance Strategies”, “the Company”, “we” or “our”). The Company is engaged in the business of purchasing or acquiring life insurance policies and residual interests in or financial products tied to life insurance policies, including notes, drafts, acceptances, open accounts receivable and other obligations representing part or all of the sales price of insurance, life settlements and related insurance contracts being traded in the secondary marketplace, often referred to as the “life settlements market.” Since the Company’s inception its operations have been primarily financed through sales of equity, debt financing from related parties and the issuance of notes payable and convertible debentures. Currently, the Company is focused on the purchase of net insurance benefit contracts (“NIBs”) based on life settlements or life insurance policies. The Company does not take possession or control of the policies. The owners of the life settlements or life insurance policies (the “Owners” or “the Holders”) acquire such policies at a discount to their face value. On settlement, the Company receives the net insurance benefit after all borrowings, interest and expenses have been paid by the Owners out of the settlement proceeds. The Owners are variable interest entities (VIEs), for which the Company has a variable interest, but is not the primary beneficiary. The Company’s investment in NIBs (see Note 3) were issued by the Owners (i.e. the VIEs). The Company’s maximum exposure to loss in the variable interest entities is limited to the investment in NIBs balance. The Company does not have the power to direct activities of the VIEs. Further, the Company does not have the contractual obligation to absorb losses of the VIE. The investment in NIBs is a residual economic beneficial interest in a portfolio of life insurance contracts that have been financed by an independent third party via a loan from a lender and, in certain cases, insured via a mortality risk insurance product or mortality re-insurance (“MRI”). Future expected cash flow and positive profits are defined as the net insurance proceeds from death benefits after senior debt repayment, mortality risk repayment, and service provider or other third-party payments. NIBs are generally in the form of participating debt certificates (“PDC”), and although the two terms are interchangeable, the Company typically refers to them as NIBs. According to the terms of the PDCs, the PDCs provide both variable and fixed interest return to the Company from the Owners of the policies in the form of accrued yield. The variable interest varies by individual PDC, and is calculated as 99% to 100% (depending on the PDC) of the positive profits from the life insurance assets held by the Owners of the policies. The fixed interest also varies by individual PDC, and is either 1% or 2% per annum of the par value of the PDCs held by the Company. The par value of the PDCs held by the Company is approximately $36.8 million. The NIBs agreements between the Company and the Owners of the policies contain a provision that allows for the Owners to redeem the NIBs at any point, conditional upon paying to the Company the par value of the NIBs, as well as any unpaid accrued yield relating to fixed and variable interest. In aggregate, the sum of the par value plus unpaid accrued interest is in excess of the Company’s initial investment. The Company holds between 72.2% and 100% in the NIBs relating to the underlying life insurance policies as of June 30, 2017 and 2016. The Company is not responsible for maintaining premiums or other expenses related to maintaining the underlying life insurance contracts. Therefore, the investment in NIBs balance on the Company’s balance sheet does not increase when premiums or other expenses are paid. At March 31, 2017, and during the three months ended June 30, 2017, the Company accounted for its investment in NIBs at the initial investment value increased for interest income and decreased for cash receipts received by the Company. At the time of transfer or purchase of an investment in NIBs, we estimated the future expected cash flows and determine the effective interest rate based on these estimated cash flows and our initial investment. Based on this effective interest rate, the Company calculated accretable income, which was recorded as interest income on investment in NIBs in the statement of operations. Our projections were based on various assumptions that are subject to uncertainties and contingencies including, but not limited to, the amount and timing of projected net cash receipts, expected maturity events, counter party performance risk, changes to applicable regulation of the investment, shortage of funds needed to maintain the asset until maturity, changes in discount rates, life expectancy estimates and their relation to premiums, interest, and other costs incurred, among other items. These uncertainties and contingencies are difficult to predict and are subject to future events that may impact our estimates and interest income. As a result, actual results could differ significantly from these projections. Therefore, subsequent to the purchase and on a regular basis, these future estimated cash flows were evaluated for changes. If the determination was made that the future estimated cash flows should be adjusted to the point of a material change in revenue, a revised effective yield was calculated prospectively based on the current amortized cost of the investment, including accrued accretion. Any positive or adverse change in cash flows would result in a prospective increase or decrease in the effective interest rate used to recognize interest income. Any significant adverse change in the cash flows that may have resulted in the recognition of an “other-than-temporary impairment” (“OTTI”), and would be evaluated by the Company accordingly. At March 31, 2017, and during the three months ended June 30, 2017, the Company’s investment in NIBs was treated as a debt security, which was classified as a hold-to-maturity asset. We evaluate the carrying value of our investment in NIBs for impairment on a regular basis and, if necessary, adjust our total basis in the NIBs using new or updated information that affects our assumptions. We recognize impairment on a NIB contract if the fair value of the beneficial interest is less than the carrying amount of the investment, plus anticipated undiscounted future premiums and direct external costs, if any, and if there are adverse changes in cash flow. We had not recognized any impairment on our investment in NIBs from inception, through the year ended March 31, 2017. However, between May 2018 and July 2018, the Owners entered into agreements that completed a strict foreclosure transaction that transferred these policies from the owners to the lenders in full satisfaction of the loan obligation. As part of the original agreement, the Chairman of the Company helped secure the loan by including a personal guarantee for a portion of the debt, if needed. The owners and other parties to the Agreements are diligently working to secure alternative financing, although no such positive outcome can be assured. As a result of the foreclosure, the Company has lost its position in the residual benefits of the policies and has reduced the carrying value of the NIBs at June 30, 2017 to $7,769,568, which is equal the actual cash received by the Company from distributions subsequent to June 30, 2017. This carrying value is less than the accretion receivable as of March 31, 2017, and as such, is considered accretion receivable and not part of the Company’s original investment.

NEW ACCOUNTING PRONOUNCEMENTS

NEW ACCOUNTING PRONOUNCEMENTS	3 Months Ended
	Jun. 30, 2017
New Accounting Pronouncements and Changes in Accounting Principles [Abstract]
NEW ACCOUNTING PRONOUNCEMENTS	(2) Adopted During the Quarter Ended June 30, 2017 In December 2015, the FASB issued ASU 2015-17, Balance Sheet Classification of Deferred Taxes. The new standard is designed to simplify the presentation of deferred income taxes, and requires all deferred tax liabilities and assets of the same tax jurisdiction or a tax filing group, as well as any related valuation allowance, be offset and presented as a single noncurrent amount in a classified balance sheet. The amendments are effective for the Company’s fiscal year beginning April 1, 2017, and for interim periods within that fiscal year. The adoption of this guidance did not have a material effect on the consolidated financial statements as the Company presents an unclassified balance sheet. In March 2016, the FASB issued ASU 2016-06 related to the embedded derivative analysis for debt instruments with contingent call or put options. This pronouncement clarifies that an exercise contingency does not need to be evaluated to determine whether it relates only to interest rates or credit risk. Instead, the contingent put or call option should be evaluated for possible bifurcation as a derivative in accordance with the four-step decision sequence detailed in FASB ASC 815-15, without regard to the nature of the exercise contingency. The pronouncement is effective for the Company’s fiscal year beginning April 1, 2017, and for interim periods within that fiscal year. The adoption of this guidance did not have a material effect on the consolidated financial statements. In March 2016, the FASB issued ASU 2016-09, Improvements to Employee Share-Based Payment Accounting. The new standard simplifies certain aspects of the accounting for share-based payment award transactions by allowing entities to continue to use current GAAP by estimating the number of awards that are expected to vest or, alternatively, entities can elect to account for forfeitures as they occur. Another aspect of the standard requires an entity to recognize all excess tax benefits and deficiencies associated with stock-based compensation as a reduction or increase to tax expense in the income statement. Previously, such amounts were recognized in additional paid-in capital. ASU 2016-09 is effective for the Company for its fiscal year beginning April 1, 2017. The adoption of this guidance did not have a material effect on the consolidated financial statements. In October 2016, the FASB issued ASU 2016-17, Consolidation - Interests held through Related Parties that are under Common Control, which alters how a decision maker needs to consider indirect interests in a variable interest entity (VIE) held through an entity under common control. Under the new ASU, if a decision maker is required to evaluate whether it is the primary beneficiary of a VIE, it will need to consider only its proportionate indirect interest in the VIE held through a common control party. The amendments in this Update are effective for fiscal years beginning April 1, 2017, including interim periods within that fiscal year. The adoption of this guidance did not have a material effect on the consolidated financial statements, as the Company has no related parties under common control that have the characteristics of a primary beneficiary of a variable interest entity. Not Yet Adopted The Financial Accounting Standards Board (“FASB”) issued Accounting Standard Update (“ASU”) 2014-09, 2015-14, 2016-8, 10,11 and 12 and 2017-13 – Revenue from Contracts with Customers, which provides a single, comprehensive revenue recognition model for all contracts with customers. The core principal of the ASUs is that an entity should recognize revenue when it transfers promised goods or services to customers in an amount that reflects the consideration to which the entity expects to be entitled in exchange for those goods or services. The ASUs also requires additional disclosure about the nature, amount, timing and uncertainty of revenue and cash flows arising from customer contracts, including significant judgments and changes in judgments and assets recognized from costs incurred to obtain or fulfill a contract. In July 2015, the FASB deferred the effective date of this standard. As a result, the standard and related amendments will be effective for the Company for its fiscal year beginning April 1, 2018, including interim periods within that fiscal year. Early application is permitted, but not before the original effective date of April 1, 2017. Entities are allowed to transition to the new standard by either retrospective application or recognizing the cumulative effect. The ASUs are not applicable to securitized beneficial interests that derive accreted yields and, therefore the Company will continue to follow the guidance in ASC 325-40. The adoption of this standard will not have an impact on the consolidated financial statements. In January 2016, the FASB issued ASU 2016-01 regarding Financial Instruments, which amended guidance on the classification and measurement of financial instruments. Under the new guidance, entities will be required to measure equity investments that are not consolidated or accounted for under the equity method at fair value with any changes in fair value recorded in net income, unless the entity has elected the new practicability exception. For financial liabilities measured using the fair value option, entities will be required to separately present in other comprehensive income the portion of the changes in fair value attributable to instrument-specific credit risk. Additionally, the guidance amends certain disclosure requirements associated with the fair value of financial instruments. The standard will be effective for the Company’s fiscal year beginning April 1, 2018, including interim reporting periods within that fiscal year. The Company is currently evaluating the effect of the adoption of this guidance on the consolidated financial statements. In February 2016, the FASB issued ASU 2016-02 related to the accounting for leases. This pronouncement requires lessees to record most leases on their balance sheet, while expense recognition on the income statement remains similar to current lease accounting guidance. The guidance also eliminates real estate-specific provisions and modifies certain aspects of lessor accounting. Under the new guidance, lease classification as either a finance lease or an operating lease will determine how lease-related revenue and expense are recognized. The pronouncement is effective for the Company’s fiscal year beginning April 1, 2019, and for interim periods within that fiscal year. The Company does not believe the adoption of this guidance will have a material effect on the consolidated financial statements because leases are month-to-month and not material to the Company’s financial statements. In June 2016, the FASB issued ASU 2016-13, Financial Instruments - Credit Losses. ASU 2016-13 requires entities to report “expected” credit losses on financial instruments and other commitments to extend credit rather than the current “incurred loss” model. These expected credit losses for financial assets held at the reporting date are to be based on historical experience, current conditions, and reasonable and supportable forecasts. This ASU will also require enhanced disclosures relating to significant estimates and judgments used in estimating credit losses, as well as the credit quality. The amendments are effective for the Company’s fiscal year beginning April 1, 2020, including interim periods within that fiscal year. The Company is currently evaluating the impact the adoption of ASU 2016-13 will have on its consolidated financial statements and results of operations. In August 2016, the FASB issued ASU 2016-15, Statement of Cash Flows - Classification of Certain Cash Receipts and Cash Payments. Historically, there has been a diversity in practice in how certain cash receipts/payments are presented and classified in the statement of cash flows. To reduce the existing diversity in practice, this update addresses the eight cash flow issues as listed in the pronouncement. The amendments in this update are effective for fiscal years beginning April 1, 2018, and interim periods within that fiscal year. Early adoption is permitted. The adoption of this standard is not expected to have a material impact on the Company’s financial statements. On May 10, 2017, the FASB issued ASU 2017-09, Scope of Modification Accounting, which amends the scope of modification accounting for share-based payment arrangements, provides guidance on the types of changes to the terms or conditions of share-based payment awards to which an entity would be required to apply modification accounting under ASC 718. For all entities, the ASU is effective for the Company’s fiscal year beginning April 1, 2018, including interim periods within that annual reporting period. Early adoption is permitted, including adoption in any interim period. The adoption of this standard is not expected to have material impact on the Company’s financial statements as the Company does not expect to make future modifications to existing share based payment awards. The Company has reviewed all other recently issued, but not yet adopted, accounting standards, in order to determine their effects, if any, on its results of operations, financial position or cash flows. Based on that review, the Company believes that none of these pronouncements will have a significant effect on its financial statements.

INVESTMENT IN NET INSURANCE BEN

INVESTMENT IN NET INSURANCE BENEFITS	3 Months Ended
	Jun. 30, 2017
Investments, All Other Investments [Abstract]
INVESTMENT IN NET INSURANCE BENEFITS	(3) INVESTMENT IN NET INSURANCE BENEFITS The balance in Investment in NIBs at June 30, 2017 and March 31, 2017, and related activity for the periods then ended were as follows: June 30, 2017 March 31, 2017 Beginning Balance $ 34,156,005 $ 29,822,186 Accretion of interest income - 5,751,689 Cash received (1,500,000) (1,417,870) Impairment of investments (24,886,437) - Ending Balance $ 7,769,568 $ 34,156,005 As outlined in Note 1, between May 2018 and July 2018, the Owners entered in agreements that completed a strict foreclosure transaction that transferred these policies to the lenders in full satisfaction of the loan obligation. As a result of the foreclosure the Company reduced the carrying value of the NIBs by $24,886,437 at June 30, 2017, to $7,769,568, which is the estimated fair value of the NIBs calculated as the actual cash received subsequent to June 30, 2017, from distributions by the Owners to the Company. The original face value of the underlying life insurance policies was $412,820,622. This value takes into account the approximately 72.2% of the NIBs associated with a portfolio of life settlement policies having a face value that originally totaled $94,000,000. One policy matured during March 2014, totaling $8,000,000. A second policy with a face value of $10,000,000 matured during November 2016. Between February and March 2017, two additional maturities occurred within one portfolio of policies, totaling $14,500,000 million in face value, both of which were earlier than was forecasted based on the life expectancy reports obtained by the Owners. During April 2017, another policy with a face value of $1,500,000 matured earlier than expected. As of June 30, 2017, the face value of the outstanding, underlying policies totaled $365,454,812, adjusting for the approximately 72.2% mentioned above. Our Investment in NIBs are classified as held-to-maturity investments at March 31, 2017 and as available-for-sale investments at June 30, 2017. The NIBs have a contractual maturity date of 25 years from inception, and the inception dates ranged from December 2011 to January 2013. The amortized cost, aggregate fair value and gross unrecognized holding gains and losses at June 30, 2017 and March 31, 2017 were as follows: June 30, 2017 March 31, 2017 Amortized Cost Basis/Net Carrying Amount $ 7,769,568 $ 34,156,005 Aggregate Fair Value (See Note 4) 7,769,568 45,643,224 Gross Unrecognized Holding Gains $ - $ 11,487,219 During April 2016 and May 2017, the Company received $1,417,870 and $1,500,000, respectively, in cash proceeds associated with maturities and miscellaneous adjustments to the underlying policies. The cash proceeds reduced the carrying value of the Company’s Investment in NIBs.

FAIR VALUE MEASUREMENTS

FAIR VALUE MEASUREMENTS	3 Months Ended
	Jun. 30, 2017
Fair Value Disclosures [Abstract]
FAIR VALUE MEASUREMENTS	(4) FAIR VALUE MEASUREMENTS As defined by ASC Topic 820, "Fair Value Measurements and Disclosures" ("ASC 820"), fair value is the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. ASC 820 also requires the consideration of differing levels of inputs in the determination of fair values. Those levels of input are summarized as follows: • Level 1: Quoted prices in active markets for identical assets and liabilities. • Level 2: Observable inputs other than Level 1 quoted prices, such as quoted prices for similar instruments in active markets, quoted prices for identical or similar instruments in markets that are not active, and model-based valuation techniques for which all significant assumptions are observable in the market. • Level 3: Unobservable inputs that are supported by little or no market activity. Level 3 assets and liabilities include financial instruments whose value is determined using pricing models, discounted cash flow methodologies, or similar techniques as well as instruments for which the determination of fair value requires significant management judgment or estimation. The level in the fair value hierarchy within which a fair value measurement in its entirety falls is based on the lowest level input that is significant to the fair value measurement in its entirety. In accordance with the disclosure requirements of ASC Topic 825, “Financial Instruments” (“ASC 825”), the tables below summarize fair value estimates for the Company’s Investment in NIBs, which both are (at June 30, 2017) are not (at March 31, 2017) required to be carried at fair value. The total of the fair value calculations presented does not represent, and should not be construed to represent, the underlying value of the Company. In estimating the fair value of the Company’s Investment in NIBs, the rate of return that a market participant would be willing to pay for each portfolio is used to recalculate the discounted estimated future cash flows. This present value is used to represent the fair value of the Investment in NIBs using level 3 inputs. Financial Instruments Required To Be Carried at Fair Value at June 30, 2017 Fair Value Measurements at June 30, 2017 Description Level 1 Level 2 Level 3 Total Investment in Net Insurance Benefits $ - $ - $ 7,769,568 $ 7,769,568 Financial Instruments Not Required To Be Carried at Fair Value at March 31, 2017 Fair Value Measurements at March 31, 2017 Description Level 1 Level 2 Level 3 Total Investment in Net Insurance Benefits $ - $ - $ 45,643,224 $ 45,643,224 The Company did not have any transfers of assets and liabilities between Levels 1, 2 and 3 of the fair value measurement hierarchy during the year ended March 31, 2017 and the three months ended June 30, 2017. At March 31, 2017, the fair value of our investment in NIBs was determined by evaluating the sum of present value of the future cash flows expected from the NIBs. Therefore, subsequent to the purchase and on a regular basis, these future estimated cash flows were evaluated for changes. If the determination was made that the future estimated cash flows should be adjusted to the point of a material change in revenue, a revised effective yield would be calculated prospectively based on the current amortized cost of the investment, including accrued accretion. At June 30, 2017, the fair value of our investment in NIBs is calculated as the actual cash received (discounted) subsequent to June 30, 2017, from distributions by the Owners to the Company. Other Financial Instruments The Company’s recorded values of cash and cash equivalents, accounts payable and accrued liabilities approximate their fair values based on their short-term nature. The recorded values of the notes payable and convertible debenture approximates the fair values as the interest rate approximates market interest rates.

NOTES PAYABLE, RELATED PARTY

NOTES PAYABLE, RELATED PARTY	3 Months Ended
	Jun. 30, 2017
Related Party Transactions [Abstract]
NOTES PAYBALE, RELATED PARTY	(5) NOTES PAYABLE, RELATED PARTY As of June 30, 2017 and March 31, 2017, the Company had borrowed $4,718,484 and $5,214,753, respectively, excluding accrued interest, from related parties under notes payable agreements that allow for borrowings of up to $6,730,000, exclusive of accrued interest. There are no covenants associated with these agreements. Of the $4,718,484 of notes payable owed as of June 30, 2017, $3,238,628 was due August 31, 2018. The remaining $1,479,856 was due November 30, 2018 (see Note 12 for subsequent due date extensions). In the event the Company completes a successful equity raise, principal and interest on notes payable totaling $4,742,007 are due in full at that time. The notes payable incur interest at 7.5%, and are collateralized by Investment in NIBs. During the three months ended June 30, 2017, the Company did not borrow any additional funds under these agreements, and repaid $496,269. Additionally, $405,519 in accrued interest was paid out during the three months ended June 30, 2017. As of June 30, 2017, the Company had availability to borrow up to $2,011,516 under these agreements. The interest associated with these notes of $23,523 and $334,626 is recorded on the balance sheet as an Accrued Expense obligation at June 30, 2017 and March 31, 2017, respectively. The related parties include a person who is the Chairman of the Board of Directors and a stockholder, and Radiant Life, LLC, an entity partially owned by the Chairman of the Board of Directors. See Note 12 for a detail of activity on the Notes Payable, Related Party subsequent to June 30, 2017.

CONVERTIBLE DEBENTURE AGREEMENT

CONVERTIBLE DEBENTURE AGREEMENT	3 Months Ended
	Jun. 30, 2017
Debt Disclosure [Abstract]
CONVERTIBLE DEBENTURE AGREEMENT	(6) CONVERTIBLE DEBENTURE AGREEMENT The Company has entered into an 8% convertible debenture agreement with Satco International, Ltd., that allows for borrowings of up to $3,000,000. The holder originally had the option to convert the outstanding principal and accrued interest to unregistered, restricted common stock of the Company on June 2, 2016. Per the agreement, the number of shares issuable at conversion shall be determined by the quotient obtained by dividing the outstanding principal and accrued and unpaid interest by 90% of the 90 day average closing price of the Company’s common stock from the date the notice of conversion is received; and the price at which the Debenture may be converted will be no lower than $1.00 per share. The original maturity date was June 2, 2016, but was later extended, through a series of extensions, to August 31, 2019. These extensions applied to both the due date and the conversion rights. See Note 12 for a detail of activity on the Convertible Debenture subsequent to June 30, 2017. As of June 30, 2017 and March 31, 2017, the Company owed $700,000 under the agreement, excluding accrued interest. During the three months ending June 30, 2017, the company borrowed $200,000 on the agreement and also repaid $200,000. In addition, the Company paid $10,000 toward accrued interest related to the Convertible Debenture. The associated interest of $107,501 and $102,488 at June 30, 2017 and March 31, 2017, respectively, is recorded on the balance sheet as an Accrued Expense obligation.

LIQUIDITY REQUIREMENTS

LIQUIDITY REQUIREMENTS	3 Months Ended
	Jun. 30, 2017
LIQUIDITY AND CAPITAL REQUIREMENTS [Abstract]
LIQUIDITY REQUIREMENTS	(7) LIQUIDITY REQUIREMENTS Since the Company’s inception, its operations have been primarily financed through sales of equity, debt financing from related parties and the issuance of notes payable and convertible debentures. As of June 30, 2017, the Company had $35,178 of cash assets, compared to $4,364 as of March 31, 2017. As of Management has concluded that its existing capital resources, and availability under its existing convertible debentures and debt agreements with related parties will be sufficient to fund its operating working capital requirements for at least the next 12 months, or through April 2020. Related parties have given assurance that their continued support, by way of either extensions of due dates, or increases in lines-of-credit, can be relied on. The Company also continues to evaluate other debt and equity financing opportunities. The accompanying financial statements have been prepared on a going concern basis under which the Company is expected to be able to realize its assets and satisfy its liabilities in the normal course of business. Due to the foreclosure on the NIBs mentioned above, the company has no current source of future revenues. In order to continue to purchase additional NIBs or remove the NIBs out of foreclosure, the Company will need to raise additional capital. Management is currently engaged in obtaining long term financing and believes that it will secure the needed additional capital within one year from the date of this filing. As management believes that additional capital is a probable outcome, the Company has the ability to continue as a going concern for a period of one year from the date of issuance of these financial statements.

COMMITMENTS, CONTINGENCIES AND

COMMITMENTS, CONTINGENCIES AND LEGAL MATTERS	3 Months Ended
	Jun. 30, 2017
Commitments and Contingencies Disclosure [Abstract]
COMMITMENTS, CONTINGENCIES AND LEGAL MATTERS	(8) COMMITMENTS, CONTINGENCIES AND LEGAL MATTERS As explained in Note 1, the Company is engaged in the business of purchasing or acquiring life insurance policies and residual interests in or financial products tied to life insurance policies, including notes, drafts, acceptances, open accounts receivable and other obligations representing part or all of the sales price of insurance, life settlements and related insurance contracts being traded in the secondary marketplace, often referred to as the “life settlements market”. The Company does not take possession or control of the policies. The owners of the life settlements or life insurance policies acquired such policies at a discount to their face value. The life insurance portfolios underlying our NIBs typically involve loans originated with 4-5 year terms. The Company has always assumed that the Holders will be able to refinance their loans at the end of the respective loan terms. However, the Holders’ Lender’s ability to offer replacement loans has always been governed by factors that are beyond the Company’s control or the control of the Holders. At June 30, 2017, the entities that own the policies maintained a total of 13 separate loan agreements with the senior lending facility, all with separate expiration dates. As of June 30, 2017, 9 of these loans had expiration dates that had lapsed, with the remaining 4 loans having maturity dates ranging from July 2017 to January 2018. During October 2017, the entities completed a refinancing of the loans that had matured and were about to mature. The agreements were with a new senior lending facility who previously provided MRI for the underlying policies. During December 2017, these new loans were extended through April 15, 2018, and did not require MRI coverage. The Holders had available credit to pay forecasted premiums and expenses on a portion of the policies until April 15, 2018, which was the renewal date of the loans on these life insurance policies. The Holders have worked with the lender to extend the loans multiple times and now, after the last loan extension expired, between May 2018 and July 2018, the lenders foreclosed on the loans associated with the underlying life insurance policies and the Company has recorded a $24,886,437 impairment on the NIBs. As of June 30, 2017, the Company had remaining accrued expenses of $271,601 relating to the costs to maintain the structure of the life insurance policies. From August 2017 to October 2017, the Company paid an additional $82,438 of these accrued expenses. During October 2017 the Company received notification from the Holders that the remaining $189,163 had been paid in full by the Holders. Subsequent to June 30, 2017, the Company has reversed the effects of the remaining $189,163 accrued liability on its balance sheet.

EARNINGS (LOSS) PER COMMON SHAR

EARNINGS (LOSS) PER COMMON SHARE	3 Months Ended
	Jun. 30, 2017
Earnings Per Share [Abstract]
EARNINGS (LOSS) PER COMMON SHARE	(9) EARNINGS (LOSS) PER COMMON SHARE Basic net income (loss) per common share is computed by dividing net income (loss) by the weighted average number of common shares outstanding during the periods. Diluted net income per common share is computed by including common shares that may be issued subject to existing rights with dilutive potential, when applicable. Dilutive common stock equivalents are primarily comprised of stock options and warrants. Potentially dilutive shares resulting from convertible debt agreements are evaluated using the if-converted method, and such amounts were not dilutive.

STOCK OPTIONS

STOCK OPTIONS	3 Months Ended
	Jun. 30, 2017
Disclosure of Compensation Related Costs, Share-based Payments [Abstract]
STOCK OPTIONS	(10) STOCK OPTIONS During the year ended March 31, 2014, the Company issued common stock options to certain directors, officers, consultants and employees. The Company has recorded stock-based compensation expense of $182,572 and $508,503 related to these options for year ended March 31, 2017 and 2016, respectively. At March 31, 2017, all stock options had vested and all expenses relating to the outstanding options had been recognized as stock-based compensation expense. On the date of grant, the contractual option terms were all 5 years, with all options have an expiration date between April and October of 2018. The number of options outstanding and exercisable at June 30, 2017 is 2,106,875. If all vested options as of June 30, 2017 were to be exercised, the Company could expect to receive $3,314,294.

INCOME TAXES

INCOME TAXES	3 Months Ended
	Jun. 30, 2017
Income Tax Disclosure [Abstract]
INCOME TAXES	(11) INCOME TAXES On December 22, 2017, the Tax Cuts and Jobs Act (“Tax Reform Act”) was signed into law by the President of the United States. The Tax Reform Act significantly revised the U.S. corporate income tax regime by, among other things, lowering the U.S. federal corporate tax rate from 35% to 21% effective for the Company’s fiscal year ended March 31, 2018. U.S. GAAP requires that the impact of tax legislation be recognized in the period in which the law was enacted. The Company will recognize the effects of the Tax Reform Act for the re-measurement of its net deferred tax liabilities during the third quarter ended December 31, 2017. This will be done in accordance with Staff Accounting Bulletin No. 118 (“SAB 118”), which provides SEC staff guidance for the application of ASC Topic 740, Income Taxes

SUBSEQUENT EVENTS

SUBSEQUENT EVENTS	3 Months Ended
	Jun. 30, 2017
Subsequent Events [Abstract]
SUBSEQUENT EVENTS	(12) SUBSEQUENT EVENTS Subsequent to June 30, 2017, the following events transpired: As further explained in Note 8, during October 2017, the Holders completed a refinancing of the loans that had matured and were about to mature. The agreements are with a new senior lending facility who previously provided MRI for the underlying policies. During December 2017, these new loans were extended through April 15, 2018, and the Holders had available credit to pay forecasted premiums and expenses on a portion of the policies until that date. Between May 2018 and July 2018, the Holders entered in agreements that completed a strict foreclosure transaction that transferred the underlying life insurance policies relating to the Company’s NIBs to the lenders in full satisfaction of the loan obligation. The Holders and other parties to the Agreements are diligently working to secure alternative financing, although no such positive outcome can be assured. As of the date of this filing, the lenders continue to pay premiums and related fees on the life insurance policies and have not yet liquidated the policies. As a result of the foreclosure, the Company has lost its position in the residual benefits of the policies and has reduced the carrying value of the NIBs at June 30, 2017 to $7,769,568, which is equal the actual cash received by the Company from distributions subsequent to June 30, 2017. This carrying value is less than the accretion receivable as of March 31, 2017, and as such, is considered accretion receivable and not part of the Company’s original investment. As of June 30, 2017, the Company had remaining accrued expenses of $271,601 relating to the costs to maintain the structure of the life insurance policies. From August 2017 to October 2017, the Company paid an additional $82,438 of these accrued expenses. During October 2017 the Company received notification from the Holders that the remaining $189,163 had been paid in full by the Holders. Subsequent to June 30, 2017, the Company has reversed the effects of the remaining $189,163 accrued liability on its balance sheet. On December 22, 2017, the Tax Cuts and Jobs Act (“Tax Reform Act”) was signed into law by the President of the United States. The Tax Reform Act significantly revised the U.S. corporate income tax regime by, among other things, lowering the U.S. federal corporate tax rate from 35% to 21% effective for the Company’s calendar year ending March 31, 2018. U.S. GAAP requires that the impact of tax legislation be recognized in the period in which the law was enacted. The Company will recognize the effects of the Tax Reform Act for the re-measurement of the net deferred tax liabilities during the third quarter ended December 31, 2017. This will be done in accordance with Staff Accounting Bulletin No. 118 (“SAB 118”), which provides SEC staff guidance for the application of ASC Topic 740, Income Taxes, in the reporting period in which the 2017 Tax Reform Act was signed into law. Effective January 1, 2018, Matthew Pearson resigned his position as the Company’s Chief Operations Officer to pursue other opportunities. As of the date of this filing, no replacement has been designated to fill his position. During February 2018, management engaged consultants to explore and analyze financing alternatives available to the Company. From February 2018 through March 2019 approximately $1,320,581 has been paid to the consultants. Effective December 5, 2018, Ty D. Mattingly resigned his position on the Company’s Board of Directors. On December 6, 2018, Glenn S. Dickman and Stephen E. Quesenberry were named to the Company’s Board of Directors. Effective December 6, 2018, three existing stockholders have contributed to the Company a portion of their common shares held at a repurchase price to the Company of USD$0.05 per share The Company intends to cancel/retire the acquired shares, which will decrease the outstanding common shares on the books of the Company. The total number of common shares canceled/retired is 8,000,000, reducing the amount of outstanding common shares from approximately 44,128,441 to 36,128,441. The Company anticipates paying the $0.05 per share repurchase price and cancelling the repurchased common shares upon a major financing event, as agreed upon between the Company and the stockholders. As of the date of this filing, the shares have been cancelled, but have not yet been repurchased by the Company. On December 6, 2018, the Company awarded three of its directors 300,000 shares each of the Company’s stock, in lieu of director compensation. The shares granted include a vesting period. On July 11, 2018, the Company issued 800,000 common shares in return for obtaining the remaining 27.8% ownership of certain NIBs (see Note 3). The transaction was recorded at $40,000, the estimated fair value of the common stock issued (which management believes approximated the fair value of the NIBs received on the date of the transaction). From July 25, 2018 to December 4, 2018, Mr. Dickman loaned the Company $450,000 through an unsecured promissory note, which bears interest at a rate of 8% annually. To date, the Company has not made any principal or interest payments under this note. As of the date hereof, the full $450,000 of principal is recorded as Notes Payable, Related Party, and the Company has accrued $15,400 of unpaid interest. From September 2017 to January 2018, the Company received $7,769,568 in cash proceeds associated with maturities and miscellaneous adjustments to other underlying policies. The cash proceeds reduced the carrying value of the Company’s Investment in NIBs. Subsequent to June 30, 2017, the Company has repaid $4,288,976 in principal on the Notes Payable, Related Party and $700,000 on the Convertible Debenture. The Company has also paid out accrued interest totaling $134,124 on the Notes Payable, Related Party and Convertible Debenture. Subsequent to June 30, 2017, the Company has borrowed an additional $1,242,500 on the Notes Payable, Related Party. As of On December 6, 2017, the note payable, related party agreement that allowed for borrowings of up to $4,600,000 at June 30, 2017, was amended to extend the due date from August 31, 2018 to August 31, 2019. Then on February 8, 2019 the note was again extended to November 30, 2020. Subsequent to June 30, 2017, the note payable, related party agreement that allowed for borrowings of up to $2,130,000 was amended to extend the due dates from November 30, 2018 to November 30, 2020, respectively. On December 7, 2017, the Company agreed to amend the agreement to extend the due date and conversion rights on the Convertible Debenture from February 28, 2018 to August 31, 2019.

INVESTMENT IN NET INSURANCE B_2

INVESTMENT IN NET INSURANCE BENEFITS (Tables)	3 Months Ended
	Jun. 30, 2017
Investments, All Other Investments [Abstract]
Summary of Investments in Net Insurance Benefits	The balance in Investment in NIBs at June 30, 2017 and March 31, 2017, and related activity for the periods then ended were as follows: June 30, 2017 March 31, 2017 Beginning Balance $ 34,156,005 $ 29,822,186 Accretion of interest income - 5,751,689 Cash received (1,500,000) (1,417,870) Impairment of investments (24,886,437) - Ending Balance $ 7,769,568 $ 34,156,005
Amortized Cost, Aggregate Fair Value and Gross Unrecognized Holding Gains and Losses	The amortized cost, aggregate fair value and gross unrecognized holding gains and losses at June 30, 2017 and March 31, 2017 were as follows: June 30, 2017 March 31, 2017 Amortized Cost Basis/Net Carrying Amount $ 7,769,568 $ 34,156,005 Aggregate Fair Value (See Note 4) 7,769,568 45,643,224 Gross Unrecognized Holding Gains $ - $ 11,487,219

FAIR VALUE MEASUREMENTS (Tables

FAIR VALUE MEASUREMENTS (Tables)	3 Months Ended
	Jun. 30, 2017
Fair Value Disclosures [Abstract]
Schedule of Fair Value of Investment in NIBs	In accordance with the disclosure requirements of ASC Topic 825, “Financial Instruments” (“ASC 825”), the tables below summarize fair value estimates for the Company’s Investment in NIBs, which both are (at June 30, 2017) are not (at March 31, 2017) required to be carried at fair value. The total of the fair value calculations presented does not represent, and should not be construed to represent, the underlying value of the Company. In estimating the fair value of the Company’s Investment in NIBs, the rate of return that a market participant would be willing to pay for each portfolio is used to recalculate the discounted estimated future cash flows. This present value is used to represent the fair value of the Investment in NIBs using level 3 inputs. Financial Instruments Required To Be Carried at Fair Value at June 30, 2017 Fair Value Measurements at June 30, 2017 Description Level 1 Level 2 Level 3 Total Investment in Net Insurance Benefits $ - $ - $ 7,769,568 $ 7,769,568 Financial Instruments Not Required To Be Carried at Fair Value at March 31, 2017 Fair Value Measurements at March 31, 2017 Description Level 1 Level 2 Level 3 Total Investment in Net Insurance Benefits $ - $ - $ 45,643,224 $ 45,643,224

ORGANIZATION AND BASIS OF PRE_2

ORGANIZATION AND BASIS OF PRESENTATION (Details) - USD ($)	Jun. 30, 2017	Mar. 31, 2017	Jun. 30, 2016	Mar. 31, 2016
Derivative [Line Items]
Par value of PDCs	$ 36,800,000
Investment in Net Insurance Benefits	$ 7,769,568	$ 34,156,005		$ 29,822,186
Minimum [Member]
Derivative [Line Items]
Percentage of NIBs held	72.20%		72.20%
Maximum [Member]
Derivative [Line Items]
Percentage of NIBs held	100.00%		100.00%

INVESTMENT IN NET INSURANCE B_3

INVESTMENT IN NET INSURANCE BENEFITS (Narrative) (Details) - USD ($)	1 Months Ended			2 Months Ended	3 Months Ended
	Jul. 31, 2017	Nov. 30, 2016	Mar. 31, 2014	Mar. 31, 2017	Jun. 30, 2017	Oct. 31, 2017	Apr. 30, 2017	May 31, 2015
Contracts that matured during the period		$ 10,000,000	$ 8,000,000	$ 14,500,000
Percentage of net insurance benefits associated with a portfolio of life settlement policies having a face value that originally totaled $94,000,000					72.20%
Original face value of Net Insurance Benefits					$ 412,820,622
Face Value Of Collateral Against Cash Advances					$ 365,454,812		$ 1,500,000	$ 94,000,000
Period of contractual maturity					25 years
Subsequent Event [Member]
Carrying value	$ 24,886,437
Reversal of prior accrual for certain unpaid costs to maintain the structure of the life insurance policies	189,163
Accrued liability paid						$ 189,163
NIB [Member]
Carrying value					$ 24,886,437
NIB [Member] | Subsequent Event [Member]
Carrying value	$ 7,769,568

INVESTMENT IN NET INSURANCE B_4

INVESTMENT IN NET INSURANCE BENEFITS (Summary of Investments in Net Insurance Benefits) (Details) - USD ($)	3 Months Ended		12 Months Ended
	Jun. 30, 2017	Jun. 30, 2016	Mar. 31, 2017
Investments, All Other Investments [Abstract]
Beginning Balance	$ 34,156,005	$ 29,822,186	$ 29,822,186
Accretion of interest income		$ 1,453,872	5,751,689
Cash received	(1,500,000)		(1,417,870)
Impairment of investments	(24,886,437)
Ending Balance	$ 7,769,568		$ 34,156,005

INVESTMENT IN NET INSURANCE B_5

INVESTMENT IN NET INSURANCE BENEFITS (Amortized Cost, Aggregate Fair Value, and Gross Unrecognized Holding Gains) (Details) - USD ($)	Jun. 30, 2017	Mar. 31, 2017
Investments, All Other Investments [Abstract]
Amortized Cost Basis/Net Carrying Amount	$ 7,769,568	$ 34,156,005
Aggregate Fair Value (See Note 4)	7,769,568	45,643,224
Gross Unrecognized Holding Gains		$ 11,487,219

FAIR VALUE MEASUREMENTS (Schedu

FAIR VALUE MEASUREMENTS (Schedule of Fair Value of Investment in NIBs) (Details) - USD ($)	Jun. 30, 2017	Mar. 31, 2017
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Investment in Net Insurance Benefits	$ 7,769,568	$ 45,643,224
Level 1 [Member]
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Investment in Net Insurance Benefits
Level 2 [Member]
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Investment in Net Insurance Benefits
Level 3 [Member]
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Investment in Net Insurance Benefits	$ 7,769,568	$ 45,643,224

NOTES PAYABLE, RELATED PARTY (D

NOTES PAYABLE, RELATED PARTY (Details) - USD ($)	3 Months Ended
	Jun. 30, 2017	Mar. 31, 2017
Related Party Transaction [Line Items]
Long-term Line of Credit	$ 4,718,484	$ 5,214,753
Long term Accrued Expense obligation	402,625	753,780
Stockholder [Member]
Related Party Transaction [Line Items]
Long-term Line of Credit	4,742,007
Line of Credit Facility, Maximum Borrowing Capacity	6,730,000
Amount due on November 30, 2018	1,479,856
Amount due on August 31, 2018	$ 3,238,628
Related party note interest rate	7.50%
Repayments of Lines of Credit	$ 496,269
Remaining borrowing capacity	2,011,516
Long term Accrued Expense obligation	23,523	$ 334,626
Accrued interest paid	$ 405,519

CONVERTIBLE DEBENTURE AGREEME_2

CONVERTIBLE DEBENTURE AGREEMENT (Details) - USD ($)	Jun. 02, 2016	Jun. 30, 2017	Jun. 30, 2016	Mar. 31, 2017
Debt Instrument [Line Items]
Convertible Debenture		$ 700,000		$ 700,000
Accrued interest		10,000
Proceeds from Convertible Debenture		200,000
Repayment of Convertible Debenture		$ 200,000
Satco International, Ltd, 8% Convertible Debenture [Member]
Debt Instrument [Line Items]
Interest rate		8.00%
Maturity date	Jun. 2, 2016	Aug. 31, 2019
Convertible Debenture		$ 700,000		700,000
Convertible debenture, terms of conversion		Per the agreement, the number of shares issuable at conversion shall be determined by the quotient obtained by dividing the outstanding principal and accrued and unpaid interest by 90% of the 90 day average closing price of the Company’s common stock from the date the notice of conversion is received; and the price at which the Debenture may be converted will be no lower than $1.00 per share.
Accrued interest		$ 107,501		$ 102,488
Satco International, Ltd, 8% Convertible Debenture [Member] | Maximum [Member]
Debt Instrument [Line Items]
Face amount of debt instrument		$ 3,000,000

LIQUIDITY REQUIREMENTS (Details

LIQUIDITY REQUIREMENTS (Details) - USD ($)	3 Months Ended
	Jun. 30, 2017	Mar. 31, 2017	Jun. 30, 2016	Mar. 31, 2016
LIQUIDITY AND CAPITAL REQUIREMENTS [Abstract]
Cash and Cash Equivalents	$ 35,178	$ 4,364	$ 6,254	$ 24,717
Monthly expenses incurred by company	100,000
Accounts Payable	540,820	508,071
Additional borrowing capacity from related party notes payable	5,507,991
Additional borrowing capacity from Convertible Debenture Agreement	3,000,000
Accrued Expenses	$ 402,625	$ 753,780

COMMITMENTS, CONTINGENCIES AN_2

COMMITMENTS, CONTINGENCIES AND LEGAL MATTERS (Details) - USD ($)	1 Months Ended	3 Months Ended
	Jul. 31, 2017	Jun. 30, 2017	Oct. 31, 2017	Mar. 31, 2017
Accrued expense		$ 402,625		$ 753,780
Maximum [Member]
Loan term		5 years
Minimum [Member]
Loan term		4 years
Subsequent Event [Member]
Accrued liability paid			$ 189,163
Accrued expense			$ 82,438
Reversal of prior accrual for certain unpaid costs to maintain the structure of the life insurance policies	$ 189,163
Carrying value	$ 24,886,437

STOCK OPTIONS (Narrative) (Deta

STOCK OPTIONS (Narrative) (Details) - USD ($)	12 Months Ended
	Mar. 31, 2017	Mar. 31, 2016	Jun. 30, 2017
Disclosure of Compensation Related Costs, Share-based Payments [Abstract]
Stock option term	5 years
Stock option expiration period	April and October of 2018
Stock-based compensation expense	$ 182,572	$ 508,503
Vested options exercised value			$ 3,314,294
Options outstanding an exercisable			2,106,875

INCOME TAXES (Details)

INCOME TAXES (Details)	1 Months Ended
	Mar. 31, 2018
Subsequent Event [Member]
Federal statutory tax rate beginning in 2018	21.00%

SUBSEQUENT EVENTS (Details)

SUBSEQUENT EVENTS (Details) - USD ($)

Feb. 08, 2019

Dec. 06, 2018

Jul. 11, 2018

Dec. 07, 2017

Mar. 31, 2018

Jul. 31, 2017

Jun. 30, 2017

Jun. 30, 2016

Jan. 31, 2018

Mar. 31, 2019

Apr. 05, 2019

Apr. 04, 2019

Dec. 04, 2018

Dec. 06, 2017

Oct. 31, 2017

Mar. 31, 2017

Subsequent Event [Line Items]

Accrued expense

$ 402,625

$ 753,780

Common stock shares outstanding

44,128,441

44,128,441

Accrued interest

$ 10,000

Repayment of related party debt

496,269

$ 150,000

Repayment of Convertible Debenture

200,000

Cash Paid for Interest

415,519

Proceeds from Issuance of Notes Payable, Related Party

$ 205,000

Subsequent Event [Member]

Subsequent Event [Line Items]

Carrying value

$ 24,886,437

Accrued expense

$ 82,438

Accrued liability paid

$ 189,163

Federal statutory tax rate beginning in 2018

21.00%

Amount paid to consultants as a financing advance

$ 1,320,581

Reversal of prior accrual for certain unpaid costs to maintain the structure of the life insurance policies

189,163

Common stock shares outstanding

36,128,441

Shares issued

800,000

Fair value of common stock issued

$ 40,000

Note payable, Related party

$ 1,672,008

Repayment of related party debt

$ 4,288,976

Repayment of Convertible Debenture

700,000

Convertible debenture

$ 0

Cash Paid for Interest

134,124

Proceeds from Issuance of Notes Payable, Related Party

1,242,500

Subsequent Event [Member] | Director One [Member]

Subsequent Event [Line Items]

Shares issued

300,000

Subsequent Event [Member] | Director Two [Member]

Subsequent Event [Line Items]

Shares issued

300,000

Subsequent Event [Member] | Director Three [Member]

Subsequent Event [Line Items]

Shares issued

300,000

Subsequent Event [Member] | Three Existing Stockholders [Member]

Subsequent Event [Line Items]

Price per share of stock repurchased

$ 0.05

Number of common shares canceled/retired

8,000,000

Subsequent Event [Member] | NIB [Member]

Subsequent Event [Line Items]

Proceeds from underlying policies

$ 7,769,568

Subsequent Event [Member] | Notes Payable Related party [Member]

Subsequent Event [Line Items]

Debt instrument, face amount

$ 2,130,000

$ 4,600,000

Maturity date

Nov. 30, 2020

Aug. 31, 2019

Nov. 30, 2020

NIB [Member]

Subsequent Event [Line Items]

Carrying value

$ 24,886,437

NIB [Member] | Subsequent Event [Member]

Subsequent Event [Line Items]

Carrying value

$ 7,769,568

Unsecured promissory note [Member] | Subsequent Event [Member] | Mr. Dickman [Member]

Subsequent Event [Line Items]

Debt instrument, face amount

$ 450,000

Debt interest rate

8.00%

Note payable, Related party

$ 450,000

Accrued interest

$ 15,400